Dermata Therapeutics, Inc. Share Price & Technical Analysis
DRMA · $1.26 (+1.61%)
Healthcare / Biotechnology
$1.26
+1.61%
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in …
Price chart
Seasonality
May has 0 positive and 4 negative years (last 5 years shown)
0% return in May, -12% avg return in past 3 year May month.
-18% return in 2026, -155% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | -45% | 0% | 27% | 0% | – | – | – | – | – | – | – | -18% |
| 25 | -7% | -6% | -4% | -24% | -13% | -19% | 3% | -7% | -12% | -32% | -9% | -26% | -156% |
| 24 | -21% | -3% | -11% | -18% | -22% | -39% | -25% | -1% | -4% | -20% | -13% | 19% | -157% |
| 23 | -29% | -10% | -69% | 27% | -1% | 0% | -21% | -7% | -12% | -44% | 27% | -15% | -152% |
| 22 | 26% | -45% | 2% | -16% | -27% | -15% | 4% | -2% | -7% | 18% | -2% | -36% | -101% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.89M
P/E ratio
—
52W high
$8.00
52W low
$1.10
Volume
41,414
Beta
0.67
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Dermata Therapeutics, Inc. share price today?
- Dermata Therapeutics, Inc. (DRMA) last traded around $1.26 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does DRMA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DRMA. Download the app for real-time alerts.
- How can I analyze Dermata Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.